Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-17

Clinical Trial Update: Effects of Alpha Lipoic Acid Supplementation on Metabolic Syndrome Markers in Young Overweight or Obese Males [NA]

View source ↗

Summary

The completed clinical trial evaluated the effects of alpha-lipoic acid supplementation on metabolic syndrome markers in young overweight or obese males.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: University of La Verne | Conditions: Metabolic Syndrome, Obesity | NA | Status: COMPLETED